Friday, September 11, 2026

Celltrion’s Remsima SC: The Leading Autoimmune Drug with 68% Market Share in Europe

Celltrion's treatments for autoimmune diseases and cancer maintain strong market positions in Europe, bolstered by stable prescriptions and new products.

How Rasmotinib and PHI-501 Could Revolutionize Cancer Treatment: Insights from Bio Europe Spring 2026

Pharos iBio showcases its cancer treatments at Bio Europe Spring 2026, seeking global partnerships for Rasmotinib and PHI-501.

LS Cable & System Bets $170 Million on Mexico: Why North America Is the Real Target

LS Cable invests 230 billion KRW in Mexico to enhance production for power and mobility, targeting North American markets and tech demands.

Nikola’s Stock Crashes 41% Amid Looming Bankruptcy Protection Filing

EtcNikola's Stock Crashes 41% Amid Looming Bankruptcy Protection Filing
Yahoo Finance
Yahoo Finance

Nikola, the American hydrogen vehicle company, saw its stock price plummet more than 41% following reports of an imminent bankruptcy protection filing.

On Friday, Nikola’s shares dropped 41.11%, closing at 44 cents on the New York Stock Exchange.

The sharp decline followed a report in The Wall Street Journal that Nikola was about to file for bankruptcy.

According to the Wall Street Journal, Nikola is working with the law firm Pillsbury to explore all available options, including a potential sale or restructuring. Sources revealed that the company is actively preparing to submit a bankruptcy protection filing.

The news immediately impacted Nikola’s stock, which had already fallen about 23% in after-hours trading the previous day. The situation worsened during regular trading hours, with the stock plunging more than 41% by the closing bell.

Check Out Our Content

Check Out Other Tags:

Most Popular Articles